Administration, Sublingual: Clinical Trials

17 trials of Administration, Sublingual, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 unknown, 2 withdrawn, 1 not yet recruiting. 6 Phase 1, 4 Not applicable, 3 Phase 3, 3 Phase 4, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Unknown 1
Not applicable4Withdrawn 2, Completed 1, Unknown 1
Phase 33Completed 1, Not yet recruiting 1, Unknown 1
Phase 43Completed 2, Unknown 1
Phase 22Completed 2
Early Phase 11Completed 1

Follow Administration, Sublingual: new trials by email Literature Review of Administration, Sublingual trials Research Report on Administration, Sublingual

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week
Cyanocobalamin 1000 Mcg Oral Tablet, Cyanocobalamin 1000 Mcg Sublingual Tablet, Proton Pump Inhibitor therapy only - Hypovitaminosis b 12
Phase 3Not yet recruitingTanta University232026-12-302025-05-13
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
Sublingual administration, Electroencephalography, Biochemical mesurements - Mild Cognitive Impairment, Anxiety State
Phase 1 / Phase 2CompletedBiomind Labs Inc.202024-12-152025-04-09
Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia
Sublingual Tablet - Chronic Insomnia
Phase 3UnknownEMS3582024-06-012023-09-07
Sublingual Melatonin for Anxiety and Pain in Elective Gynecologic Surgery
Melatonin 3 mg Sublingual, Melatonin 6 mg Sublingual - Anxiety, Postoperative Pain
Not applicableCompletedBenha University962024-01-152025-06-11
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
Intravenous Infusion, Sublingual Tablet - Cancer Pain, Breakthrough Pain
Not applicableWithdrawnSeoul National University2022-12-012023-08-07
DSUVIA Early Evaluation of Pain Trial
Sufentanil 30 MCG Sublingual Tablet, standard care pain treatment - Traumatic Injury
Phase 3CompletedFrank Guyette1502022-08-052025-04-30
Melatonin Versus Hydroxizin for Pre Operative Anxiety in Elderly Patients With Hip Fracture
Melatonin 5 MG Sublingual Tablet, Hydroxyzine - Preoperative Anxiety
Not applicableUnknownMongi Slim Hospital502022-03-012022-02-04
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients
Sublingual Tablet - Spine Fusion, Pain, Postoperative
Phase 4CompletedBrigham and Women's Hospital1992020-12-012025-03-30
Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
Y-2(Edaravone And Borneol) Sublingual Tablet - Stroke, Acute, Intracranial Hemorrhages
Phase 1UnknownYantai YenePharma Co., Ltd.242018-10-252020-02-17
Evaluating MED2005 & Nitrostat Bioavailability
MED2005, Nitrostat 0.6Mg Sublingual Tablet, Nitro Pohl - Erectile Dysfunction
Phase 1CompletedFutura Medical Developments Ltd.402017-11-152019-07-05
Esophageal Food Impaction
Nitrostat 0.4Mg Sublingual Tablet - Esophageal Food Bolus Obstruction
Phase 4CompletedHealthPartners Institute202017-08-252023-02-08
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
Sublingual tablet 4 mg versus Nicorette Lozenge 4mg - Tobacco Use Disorder, Cigarette Smoking
Phase 1CompletedFriends Research Institute, Inc.242017-05-252017-12-04
The Effects of Buprenorphine on Responses to Verbal Tasks
Buprenorphine 0.2 MG Sublingual Tablet, Placebo, Buprenorphine 0.4 MG Sublingual Tablet - Basic Science
Early Phase 1CompletedUniversity of Chicago482013-09-012019-08-01
Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet
zopiclone, zolpidem tartrate sublingual tablet, Placebo (sublingual tablet) - Insomnia
Phase 1CompletedTranscept Pharmaceuticals402010-06-012012-02-14
Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians
Flow Mediated Doppler (FMD), Nitroglycerin 0.4 mg sublingual - Healthy
Not applicableWithdrawnNorthwell Health2010-04-012013-06-12
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches
Buprenorphine patch and sublingual tablets - Heroin Addiction
Phase 4UnknownPsychiatric University Hospital, Zurich102008-08-012008-09-10
Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Tizanidine (sublingual or oral) - Muscle Spasticity
Phase 1 / Phase 2CompletedTeva GTC202006-12-012009-01-21

Conditions studied

Anxiety Disorders (2)  ·  Pain, Postoperative (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Agnosia (1)  ·  Breakthrough Pain (1)  ·  Cancer Pain (1)  ·  Cigarette Smoking (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Erectile Dysfunction (1)  ·  Heroin Dependence (1)  ·  Hip Fractures (1)  ·  Intracranial Hemorrhages (1)  ·  Multiple Sclerosis (1)  ·  Muscle Spasticity (1)

Sponsors

Benha University (1)  ·  Biomind Labs Inc. (1)  ·  Brigham and Women's Hospital (1)  ·  EMS (1)  ·  Frank Guyette (1)  ·  Friends Research Institute, Inc. (1)  ·  Futura Medical Developments Ltd. (1)  ·  HealthPartners Institute (1)  ·  Mongi Slim Hospital (1)  ·  Northwell Health (1)  ·  Psychiatric University Hospital, Zurich (1)  ·  Seoul National University (1)  ·  Tanta University (1)  ·  Teva GTC (1)  ·  Transcept Pharmaceuticals (1)

Countries

United States (6)  ·  Argentina (1)  ·  Brazil (1)  ·  Egypt (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Annemiek Vermeeren, PhD (1)  ·  Arnon Karni, MD (1)  ·  Frank J Vocci, Ph.D. (1)  ·  Harriet de Wit, Ph.D. (1)  ·  Jason Sperry, MD (1)  ·  Jee Youn Moon, MD, PhD (1)  ·  Jerome Jaffe, M.D. (1)  ·  Lukas Boesch, PhD (1)  ·  Martin A. Bruno, PhD (1)  ·  Rajiv Jauhar, MD (1)  ·  Richard D. Urman, MD (1)  ·  Rudolf Stohler, MD (1)  ·  Sam Stellpflug, MD (1)  ·  Samuel Israel, Israel (1)

Results publications

PMID 24587571, PMID 39919020